iv glutathione and vitamin c Book 2400mg + Skin Drip in UAE with myAster Glutathione Vitamin C IV Therapy

Specific concerns include theoretical copper exposure with repeated systemic dosing, a conceptual contraindication in Wilsons disease and other copper-metabolism disorders, and the sterility and impurity risks of injecting research-grade material that is not a sterile pharmaceutical product

Concerns about weight gain are unfounded, as these injections do not lead to an increase in body weight

The Theory: By delivering the peptide directly to the source of the problem, you achieve the highest possible concentration of the compound where it's needed most

doi: 10.3389/fcell.2020.624477 Received 31 October 2020 Accepted 23 December 2020 Published 22 January 2021 Volume 8 - 2020 Edited by Silvia Brunelli, University of Milano-Bicocca, Italy Reviewed by Annarita Miccio, INSERM U1163 Institut Imagine, France